World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 50 4271 3945 6 6 180 7660

Gary L. Norman publications per year

The chart shows the history of publications by Gary L. Norman between 1989 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Gary L. Norman published across 37 years, from 1989 to 2025, averaging 5.2 papers a year. Output peaked at 13 publications in 2015. 5 of the 191 publications appeared in the last two years.

No. of publications
5 10
Bar chart. Horizontal axis: year, 1989 to 2025. Vertical axis: number of publications, 0 to 13. Peak 13 publications in 2015. 1989: 1 publication 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 2 publications 1997: 0 publications 1998: 0 publications 1999: 0 publications 2000: 3 publications 2001: 1 publication 2002: 3 publications 2003: 7 publications 2004: 4 publications 2005: 1 publication 2006: 6 publications 2007: 12 publications 2008: 7 publications 2009: 7 publications 2010: 9 publications 2011: 12 publications 2012: 12 publications 2013: 9 publications 2014: 6 publications 2015: 13 publications 2016: 10 publications 2017: 12 publications 2018: 11 publications 2019: 9 publications 2020: 11 publications 2021: 7 publications 2022: 4 publications 2023: 7 publications 2024: 4 publications 2025: 1 publication
1989 2025

191 publications in total across all disciplines

View publications per year as a table
Gary L. Norman: publications per year, 1989 to 2025
Year Publications
1989 1
1990 0
1991 0
1992 0
1993 0
1994 0
1995 0
1996 2
1997 0
1998 0
1999 0
2000 3
2001 1
2002 3
2003 7
2004 4
2005 1
2006 6
2007 12
2008 7
2009 7
2010 9
2011 12
2012 12
2013 9
2014 6
2015 13
2016 10
2017 12
2018 11
2019 9
2020 11
2021 7
2022 4
2023 7
2024 4
2025 1
Total 191
Download as CSV

Gary L. Norman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gary L. Norman sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 172–181 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 180 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181 180
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Gary L. Norman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gary L. Norman sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 50–51 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188 50
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Gary L. Norman is affiliated with the University of Debrecen in Hungary and has contributed extensively to the field of medicine, with a focus on epidemiology, hepatology, gastroenterology, surgery, and rheumatology. Their research covers several key topics, including celiac disease research and management, liver diseases and immunity, systemic lupus erythematosus research, liver disease diagnosis and treatment, platelet disorders and treatments, microscopic colitis, and studies involving S100 proteins and annexins.

Norman's recent scholarly contributions include the following notable papers:

  • "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort, 2020, Arthritis Research & Therapy
  • Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients, 2020, World Journal of Gastroenterology
  • Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study, 2023, The Lancet. Gastroenterology & Hepatology
  • Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG, 2020, Clinical Gastroenterology and Hepatology
  • Anti-Domain I β2-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study, 2020, The Journal of Applied Laboratory Medicine

The scientist has collaborated frequently with colleagues across various studies. Frequent co-authors include:

  • Michael Mähler, with 10 joint publications
  • Zakera Shums, with 6 joint publications
  • Julio C. Bai, with 5 joint publications
  • Edgardo Smecuol, with 5 joint publications
  • Ewa Wunsch, with 5 joint publications

Norman's research outputs have been published repeatedly in several key venues, illustrating their ongoing engagement with the academic community. These venues include:

  • Diagnostics (3 publications)
  • Journal of Hepatology (3 publications)
  • The American Journal of Gastroenterology (2 publications)
  • Clinical Chemistry and Laboratory Medicine (CCLM) (2 publications)
  • Arthritis Research & Therapy (1 publication)

Across their professional work, Norman engages deeply with clinical and laboratory research relating to immune-mediated diseases, liver pathology, and gastrointestinal disorders. Their work spans multidisciplinary areas intersecting immunology, hepatology, and gastroenterology, reflecting a broad yet focused research profile within medicine.

Best Publications

  • Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

    Minoru Nakamura;Hisayoshi Kondo;Tsuyoshi Mori;Atsumasa Komori

  • New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

    Marc Ferrante;Liesbet Henckaerts;Marie Joossens;Marie Pierik

  • Autoimmune acute liver failure: proposed clinical and histological criteria.

    R. Todd Stravitz;Jay H. Lefkowitch;Robert J. Fontana;M. Eric Gershwin

  • AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

    Kentaroh Yamamoto;Hiroshi Imamura;Yutaka Matsuyama;Yukio Kume

  • New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.

    Mária Papp;István Altorjay;Nir Dotan;Károly Palatka

  • IL-2 receptor alpha deficiency and features of primary biliary cirrhosis.

    Christopher A Aoki;Chaim M Roifman;Zhe-Xiong Lian;Christopher L Bowlus

  • Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency.

    Edith Lahner;Gary L Norman;Carola Severi;Susan Encabo

  • Utility of serological markers in inflammatory bowel diseases: gadget or magic?

    Maria Papp;Gary L Norman;Istvan Altorjay;Peter Laszlo Lakatos

  • Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.

    Shervin Assassi;Marvin J. Fritzler;Frank C. Arnett;Gary L. Norman

  • Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis

    Patrick S C Leung;Lorenzo Rossaro;Paul A. Davis;Ogyi Park

  • PBC Screen An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis

    Haiying Liu;Gary L. Norman;Zakera Shums;Howard J. Worman

  • Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.

    Laura Andreoli;Cecilia B. Chighizola;Cecilia Nalli;Maria Gerosa

  • Value of Isolated IgA Anti–β2‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome

    Vijaya Murthy;Rohan Willis;Rohan Willis;Zurina Romay-Penabad;Patricia Ruiz-Limõn;Patricia Ruiz-Limõn

  • Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their ‘innocent’ profile?

    Laura Andreoli;Cecilia Nalli;Mario Motta;Gary L. Norman

  • Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients

    Maria Papp;Istvan Altorjay;Gary L. Norman;Zakera Shums

  • Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome.

    Michael Mahler;Gary L. Norman;Pier Luigi Meroni;Munther Khamashta

  • The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies

    Masanobu Tsuda;Troy R. Torgerson;Carlo Selmi;Eleonora Gambineri

  • Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.

    Hui Shi;Hui Zheng;Yu-Feng Yin;Qiong-Yi Hu

  • Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.

    Navid Zohoury;Maria Laura Bertolaccini;Jose Luis Rodriguez-Garcia;Zakera Shums

  • Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of β2-GPI

    G. Michael Iverson;Carlos A. von Mühlen;Henrique L. Staub;Andrew J. Lassen

Frequent Co-Authors

Michael Mahler
Michael Mahler Heidelberg University
Peter L. Lakatos
Peter L. Lakatos McGill University
Dimitrios P. Bogdanos
Dimitrios P. Bogdanos University Of Thessaly
M. Eric Gershwin
M. Eric Gershwin University of California, Davis
Patrick S.C. Leung
Patrick S.C. Leung University of California, Davis
Albert J. Czaja
Albert J. Czaja Mayo Clinic
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano
Angela Tincani
Angela Tincani University of Brescia
Diego Vergani
Diego Vergani King's College London
Albert Parés
Albert Parés University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing Immunology in the USA, branching into nursing and related healthcare fields offers diverse career options. Many students explore practical nursing opportunities, with programs that feature lpn programs with easiest admission requirements providing accessible entry points.

Advancing further, aspiring healthcare professionals often consider nurse practitioner degrees. Identifying which nurse practitioner program is easiest to gain admission to can help streamline the path toward advanced clinical roles.

For specialization in psychiatric care, online options abound. Many look into the best pmhnp programs that ensure strong clinical placement rates, essential for hands-on experience and licensure requirements.

Cost is often a decisive factor; thus, exploring cheapest online pmhnp programs can make advanced psychiatric nursing education more attainable without sacrificing quality.

Best Scientists Citing Gary L. Norman

Trending Scientists

Recently Published Articles